"I know this is on my chest, let's act": a qualitative study exploring self-management of acute COPD exacerbations with a sputum colour chart to reduce unnecessary antibiotic use
- PMID: 39616147
- PMCID: PMC11608216
- DOI: 10.1038/s41533-024-00398-3
"I know this is on my chest, let's act": a qualitative study exploring self-management of acute COPD exacerbations with a sputum colour chart to reduce unnecessary antibiotic use
Abstract
Half of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are caused by bacterial infection, but self-management plans (SMPs) generally advocate use of antibiotics and steroids for all events. We report findings from a qualitative study exploring the acceptability of a sputum colour chart and SMP to guide patient use of antibiotics and steroids (commonly termed a 'rescue pack'). Qualitative interviews were conducted with healthcare professionals (HCPs) and patients from the Colour COPD trial - a randomised controlled trial of usual care (SMP alone) versus usual care plus sputum colour chart to manage AECOPD across England and sampled to promote maximum variation. Interviews were audio-recorded, transcribed clean verbatim, then analysed thematically, using an adapted Framework approach. Expert patients contributed to the patient data analysis. Fourteen HCPs and 39 patients were interviewed from primary and secondary care. Three overarching themes were identified. (1) Handling tensions: the tension between stewardship of antimicrobials and need to reduce risk of serious illness. (2) Clinical and embodied legacies: established clinical practices of infection control and patient's own experiences of managing their condition over time have focused on early intervention for AECOPD. (3) Changing self-management practices: opportunities for changing practices through negotiating change between HCP and patient. In conclusion, while, in principle, the assessment of sputum colour using a chart to manage AECOPD was acceptable to both patients and HCPs, in practice, it is unlikely to have significant impact on well-established clinical practices for infection control and patient habits of self-management.
© 2024. The Author(s).
Conflict of interest statement
Competing interests: MM declares no financial or non-financial competing interests. All other authors received funding for their contributions to this study, they declare no non-financial competing interests.
References
-
- British Lung Foundation. The battle for breath - the impact of lung disease in the UK. London: British Lung Foundation (2016).
-
- British Lung Foundation. Estimating the economic burden of respiratory illness in the UK. London: British Lung Foundation (2016).
-
- Global Initiative for Obstructive Lung Disease (GOLD)Science Committee. 2020 Global Strategy for Prevention, Diagnosis and Management of COPD. Available from www.goldcopd.com, published in Deer Park, IL, USA (2020).
-
- Anthonisen, N. R. et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med106, 196–204 (1987). - PubMed
-
- Seemungal, T. A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med.157, 1418–1422 (1998). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
